June 25th 2025
Marketed as Orlynvah, oral sulopenem from Iterum Therapeutics was FDA approved last fall for uncomplicated urinary tract infections and has shown efficacy against infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.
Identifying Deficiencies in Nursing Home Antibiotic Stewardship Implementation
September 29th 2021In research presented virtually at IDWeek 2021, investigators with the Centers for Disease Control and Prevention (CDC) conducted a review of nursing home antibiotic stewardship citation deficiencies in order to improve implementation.
Read More
Daptomycin as Frontline Therapy for MRSA Bacteremia: Has the Time Come?
Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.
Read More
Preventing Multidrug-Resistant Spread in Healthcare Facilities
August 16th 2021The interconnectedness of many healthcare facilities such as nursing homes, hospitals, and long-term acute-care hospitals means a significant chance of multidrug-resistant organism transmission when patients shuttle between facilities.
Read More